Search
Haemonetics Corp
HAEAdd to Watchlist
119.930USD
-4.180-3.37%
Close 11-06 16:00（ET）
5.46BMarket Cap
58.16P/E TTM
After-hours 19:00 (ET)119.930USD+0.145+0.12%
After-hours 19:00 (ET)Today
-3.37%
5 Days
+0.23%
1 Month
+15.85%
6 Months
+127.70%
Year to Date
+49.63%
1 Year
+78.71%
Key Figures
121.160Open
132.000High
80.46KVolume
58.16P/E TTM
22.61P/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
124.110Prev. Close
117.190Low
9.63MTurnover
32.55P/E Static
6.08P/B
0.00%Div Yield TTM
4.02%ROA
132.00052wk High
0.12Volume Ratio
167.68MNet Profit
45.50MShares
2.0625EPS TTM
0.55Beta
12.03%ROE
51.00052wk Low
11.93%Amplitude
58.78%Gross Margin
5.46BMarket Cap
6.84Reward/Risk
2.58%Risk Rate
Haemonetics Corp's Score
-0.02vs previous score
Forecast8.55
Financial Health7.43
Technical3.32
Valuation Dimensions8.90
Institutional Confidence10.00
Risk Assessment7.25
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Haemonetics Corp Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Neutral
Haemonetics Corp Latest Earnings Call Transcripts
Haemonetics (HAE) Fiscal Q2 2027 Earnings Call: Revenue Outlook Raised
Haemonetics fiscal Q2 2027 earnings call: organic revenue grew 10%, Plasma rose 18%, and management raised full-year revenue guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2027Q2
Earnings / Forecast
1.02/1.29
Revenue / Forecast
357.76M/345.00M
Haemonetics Corp Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolHAE
Number of employees3023
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 11.10% |
| Neuberger Berman, LLC | 8.32% |
| AQR Capital Management, LLC | 6.81% |
| Vanguard Portfolio Management, LLC | 5.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 46.74% |
| Investment Advisor/Hedge Fund | 45.50% |
| Hedge Fund | 15.00% |
| Research Firm | 6.52% |
Related Instruments
-0.40%
+2.63%
-3.23%
+1.73%
-3.36%
-2.90%
-2.75%
+3.10%
-2.46%
-1.48%
-2.62%
-1.80%
-4.23%
+1.31%
-0.78%
+0.79%
-0.30%
+5.33%
+1.73%
-2.05%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Haemonetics Corp (HAE)?
The current price of Haemonetics Corp (HAE) is 119.93.
What is the symbol of Haemonetics Corp?
The ticker symbol of Haemonetics Corp is HAE.
What is the 52-week high of Haemonetics Corp?
The 52-week high of Haemonetics Corp is 132.00.
What is the 52-week low of Haemonetics Corp?
The 52-week low of Haemonetics Corp is 51.00.
What is the market capitalization of Haemonetics Corp?
The market capitalization of Haemonetics Corp is 5.46B.
Is Haemonetics Corp (HAE) currently rated as Buy, Hold, or Sell?
According to analysts, Haemonetics Corp (HAE) has an overall rating of Buy, with a price target of 142.78.
What is the Earnings Per Share (EPS TTM) of Haemonetics Corp (HAE)?
The Earnings Per Share (EPS TTM) of Haemonetics Corp (HAE) is 2.06.